Clinical development of Modified Vaccinia virus Ankara vaccines.
The smallpox vaccine Vaccinia was successfully used to eradicate smallpox, but although very effective, it was a very reactogenic vaccine and responsible for the deaths of one or two people per million vaccinated. Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivat...
Glavni avtor: | Gilbert, S |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
2013
|
Podobne knjige/članki
-
Clinical development of Modified Vaccinia virus Ankara vaccines
od: Gilbert, S
Izdano: (2013) -
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
od: Olga Vladimirovna Orlova, et al.
Izdano: (2022-09-01) -
Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
od: Gilbert, S, et al.
Izdano: (1999) -
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
od: Moorthy, V, et al.
Izdano: (2003) -
Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
od: Kaïdre Bendjama, et al.
Izdano: (2017-09-01)